Cargando…
Correction: Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435361/ https://www.ncbi.nlm.nih.gov/pubmed/28545046 http://dx.doi.org/10.1371/journal.pone.0178275 |
Ejemplares similares
-
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
por: Sarshekeh, Amir Mehrvarz, et al.
Publicado: (2017) -
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
por: Xu, Juan, et al.
Publicado: (2023) -
Correction to: Demographic Characteristics and Clinical Features of Fibromyalgia in China: A Cross-Sectional Study
por: Jiao, Juan, et al.
Publicado: (2021) -
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53–Mutated Metastatic Colorectal Cancer
por: Lahoz, Sara, et al.
Publicado: (2022) -
Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer
por: Li, Yongmin, et al.
Publicado: (2017)